FDA approves Eli Lilly’s obesity medication for obstructive sleep apnea
The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe ...
Novo’s Obesity Shot Shortfall Shows Danger of Promising Too Much
Novo Nordisk A/S’s failure to meet its own bar for success on a next-generation obesity shot shows the danger of promising ...
From adolescence to adulthood: Unlocking cognitive potential in individuals with Down syndrome
A new study has revealed encouraging findings about cognitive growth and development in adults with non-specific intellectual ...
Irish Examiner on MSN5d
Shaping Futures: How Futsal is changing lives for athletes with Down syndrome
In a brightly-lit gym in the Blanchardstown Campus sports hall, the Irish Futsal team gathers for its monthly training ...